Covered recipient · General Payments record
KENNEDI PAIGE HARRISON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Obstetrics & Gynecology
General Payments · PY2022–2024
$545.95
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.40 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $58.41 | 3 |
| ABBVIE INC. | $57.59 | 3 |
| Organon LLC | $53.94 | 4 |
| Biogen, Inc. | $53.58 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $31.67 | 1 |
| PFIZER INC. | $26.31 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.13 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107296985 | CMS |
| ABBVIE INC. | $22.09 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107296987 | CMS |
| ABBVIE INC. | $16.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107296989 | CMS |
| Astellas Pharma US Inc | $21.79 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560509 | CMS |
| Astellas Pharma US Inc | $19.16 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502641 | CMS |
| Astellas Pharma US Inc | $17.46 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139556273 | CMS |
| Biogen, Inc. | $27.99 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104865060 | CMS |
| Biogen, Inc. | $25.59 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104816845 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $31.67 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670771 | CMS |
| Organon Llc | $1.34 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213626 | CMS |
| Organon Llc | $12.26 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213628 | CMS |
| Organon Llc | $17.98 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213630 | CMS |
| Organon Llc | $22.36 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136213632 | CMS |
| PFIZER INC. | $13.14 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131604457 | CMS |
| PFIZER INC. | $13.17 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131604461 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.90 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105907655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.